Iniciar sesión

Yuchuan Jiang

Department of Hepatobiliary Surgery,
The First Affiliated Hospital,
Department of Hepatobiliary Surgery, The First Affiliated Hospital

jinan university

BIOGRAPHY

Yuchuan Jiang has not added Biography.

If you are Yuchuan Jiang and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

CD215+ Myeloid Cells Respond to Interleukin 15 Stimulation and Promote Tumor Progression.

Frontiers in immunology , 2017 | Pubmed ID: 29255466

Dexmedetomidine promotes the progression of hepatocellular carcinoma through hepatic stellate cell activation.

Experimental & molecular medicine Jul, 2020 | Pubmed ID: 32632241

Pyruvate Kinase M2 Tetramerization Protects against Hepatic Stellate Cell Activation and Liver Fibrosis.

The American journal of pathology Nov, 2020 | Pubmed ID: 32805235

Intrahepatic cholangiocarcinoma induced M2-polarized tumor-associated macrophages facilitate tumor growth and invasiveness.

Cancer cell international Dec, 2020 | Pubmed ID: 33372604

Inflammatory microenvironment of fibrotic liver promotes hepatocellular carcinoma growth, metastasis and sorafenib resistance through STAT3 activation.

Journal of cellular and molecular medicine Feb, 2021 | Pubmed ID: 33410581

Myofibroblast-Specific Msi2 Knockout Inhibits HCC Progression in a Mouse Model.

Hepatology (Baltimore, Md.) 07, 2021 | Pubmed ID: 33609283

TANK-Binding Kinase 1 (TBK1) Serves as a Potential Target for Hepatocellular Carcinoma by Enhancing Tumor Immune Infiltration.

Frontiers in immunology , 2021 | Pubmed ID: 33679751

Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With FOLFOX in Hepatocellular Carcinoma With Microvascular Invasion: A Multicenter, Phase III, Randomized Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology Dec, 2022 | Pubmed ID: 36525610

Serine/threonine kinase TBK1 promotes cholangiocarcinoma progression via direct regulation of β-catenin.

Oncogene May, 2023 | Pubmed ID: 36928362

A novel prognostic biomarker: is correlated with methylation and immune escape in liver hepatocellular carcinoma.

Translational cancer research May, 2023 | Pubmed ID: 37304536

Noncanonical regulation of HOIL-1 on cancer stemness and sorafenib resistance identifies pixantrone as a novel therapeutic agent for hepatocellular carcinoma.

Hepatology (Baltimore, Md.) Oct, 2023 | Pubmed ID: 37820061

GINS1 promotes ZEB1-mediated epithelial-mesenchymal transition and tumor metastasis via β-catenin signaling in hepatocellular carcinoma.

Journal of cellular physiology May, 2024 | Pubmed ID: 38468464

INSTITUTIONS

jinan university

the First Affiliated Hospital, Jinan University

The Second Affiliated Hospital, Nanchang University

the second affiliated hospital of nanchang university

JOVE ARTICLES

Laparoscopic Common Bile Duct Exploration in Patients with a Previous History of Biliary Tract Surgery

Junjie Liang^*,1,

Jiexing Li^*,1,

Yuchuan Jiang¹,

Qiang Li¹,

Zhilong Liu¹,

Leyang Xiang¹,

Youzhu Hu^1,2,

Mingrong Cao¹

¹Department of Hepatobiliary Surgery, The First Affiliated Hospital, Jinan University,

²Department of General Surgery, The Affiliated Shunde Hospital, Jinan University

Medicine

Laparoscopic Posterior Radical Antegrade Modular Pancreatosplenectomy for Distal Pancreatic Carcinoma

Junjie Liang^*,1,

Quan Jiang^*,1,

Leyang Xiang^*,1,

Yuchuan Jiang^1,2,

Jiexing Li¹,

Zhilong Liu¹,

Qiang Li¹,

Mingrong Cao¹,

Youzhu Hu^1,3,

Jian Sun¹

¹Department of Hepatobiliary Surgery, The First Affiliated Hospital, Jinan University,

²Department of Gastroenterology, The Second Affiliated Hospital, Nanchang University,

³Department of General Surgery, The Affiliated Shunde Hospital, Jinan University

Medicine

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Qiang Li^*,1,

Xiaolan Wang^*,1,2,

Deju Li^*,1,

Yulong Liu^*,3,

Kangshou Liu¹,

Junjie Liang¹,

Jian Sun¹,

Quan Jiang¹,

Jiexing Li¹,

Zhilong Liu¹,

Jian Gong⁴,

Leyang Xiang¹,

Zhidong Jia¹,

Zhiwei Chen¹,

Mingrong Cao¹,

Yuchuan Jiang^1,5

¹Department of Hepatobiliary Surgery, The First Affiliated Hospital, Jinan University,

²Dongpu Branch, The First Affiliated Hospital, Jinan University,

³Department of Vascular Intervention, The First Affiliated Hospital, Jinan University,

⁴Department of Nuclear Medicine, The First Affiliated Hospital, Jinan University,

⁵Department of Gastroenterology, The Second Affiliated Hospital of Nanchang University

Medicine

Privacidad

Condiciones de uso

Políticas

Contáctenos

RECOMIENDE A LA BIBLIOTECA

BOLETINES de JoVE

Investigación

JoVE Journal
Colecciones de métodos
JoVE Encyclopedia of Experiments
Archivo

Educación

JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Business
JoVE Quiz
JoVE Playlist
Faculty Site

Autores

Descripción
Proceso de publicación
Comité editorial
Ámbito y políticas
Revisión por pares
Preguntas frecuentes
Enviar

Bibliotecarios

Descripción
Testimonios
Suscripciones
Acceso
Recursos
Junta Asesora de Bibliotecarios
Preguntas frecuentes

ACERCA DE JoVE

Descripción
Liderazgo
Blog
JoVE Help Center
JoVE Sitemap

Utilizamos cookies para mejorar su experiencia en nuestra página web.

Al continuar usando nuestro sitio web o al hacer clic en 'Continuar', está aceptando nuestras cookies.

Saber más

Yuchuan Jiang

Department of Hepatobiliary Surgery,The First Affiliated Hospital,Department of Hepatobiliary Surgery, The First Affiliated Hospital

jinan university

Laparoscopic Common Bile Duct Exploration in Patients with a Previous History of Biliary Tract Surgery

Laparoscopic Posterior Radical Antegrade Modular Pancreatosplenectomy for Distal Pancreatic Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Department of Hepatobiliary Surgery,
The First Affiliated Hospital,
Department of Hepatobiliary Surgery, The First Affiliated Hospital